Crossmark

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Crossref DOI link: https://doi.org/10.1007/s00535-017-1325-2

Published Online: 2017-03-20

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suzuki, Yasuo

Motoya, Satoshi

Hanai, Hiroyuki

Hibi, Toshifumi

Nakamura, Shiro

Lazar, Andreas

Robinson, Anne Martin

Skup, Martha

Mostafa, Nael Mohamed

Huang, Bidan

Thakkar, Roopal

Watanabe, Mamoru
Funding

Funding for this research was provided by:

AbbVie
License Information

License valid from 2017-03-20